AstraZeneca

AZ/Daiichi Sankyo’s Enhertu gets second US cancer indication
Pharmaforum
Mon, 01/18/21 - 01:15 pm
AstraZeneca
Daiichi Sankyo
stomach cancer
Enhertu
Roche
Herceptin
Aducanumab tops 2021’s biggest potential launches
EP Vantage
Mon, 01/18/21 - 01:04 pm
drug launches
Biogen
Eisai
aducanumab
efgartigimod
Argenx
Evrenzo
FibroGen
Astellas
AstraZeneca
Leqvio
Novartis
UCB Pharma
bimekizumab
Ascendis Pharma
Bluebird Bio
Bristol-Myers Squibb
ide-cel
liso-cel
AXS-05
Axsome Therapeutics
voclosporin
Aurinia
10 key clinical trials to watch in the first half of 2021
BioPharma Dive
Sun, 01/17/21 - 05:01 pm
clinical trials
Novavax
AstraZeneca
JNJ
vaccines
COVID-19
Biomarin
Amgen
Merck
Pfizer
Roche
SAGE Therapeutics
Biogen
Vertex Pharmaceuticals
AstraZeneca's Farxiga gets rough FDA review date for groundbreaking move into chronic kidney disease
Endpoints
Wed, 01/6/21 - 11:03 am
AstraZeneca
Farxiga
FDA
chronic kidney disease
Newly acquired Alexion pays $100M for Rhythm's speedy review voucher
Fierce Biotech
Wed, 01/6/21 - 10:54 am
AstraZeneca
Alexion
Rhythm
priority review vouchers
Astrazeneca shows megamergers were still possible in 2020
EP Vantage
Wed, 01/6/21 - 10:41 am
M&A
AstraZeneca
Alexion
Bristol-Myers Squibb
MyoKardia
Bayer
Asklepios
Merck
VelosBio
Gilead Sciences
Forty Seven
Immunomedics
JNJ
Momenta
US won't get AstraZeneca COVID-19 vaccine until April, Warp Speed chief says
Beckers Hospital Review
Tue, 01/5/21 - 10:24 am
COVID-19
vaccines
AstraZeneca
Moncef Slaoui
First person receives AstraZeneca’s COVID-19 vaccine in the UK
Biopharma Reporter
Mon, 01/4/21 - 10:28 am
AstraZeneca
vaccines
UK
COVID-19
Corporate and regulatory developments over the holidays
EP Vantage
Mon, 01/4/21 - 10:20 am
AstraZeneca
Bristol-Myers Squibb
Celltrion
Cullinan Oncology
JNJ
Myovant Sciences
Osmotica Pharmaceuticals
Pfizer
Y-mAbs Therapeutics
United Therapeutics
Zai Lab
10 Biopharma Stories to Look Forward to in 2021
BioSpace
Sun, 01/3/21 - 04:39 pm
pandemic
COVID-19
vaccines
Joe Biden
drug pricing
M&A
venture capital
JNJ
Biomarin
Bluebird Bio
TG Therapeutics
Biogen
AstraZeneca
Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.
Motley Fool
Sun, 01/3/21 - 04:27 pm
Pfizer
BioNTech
vaccines
UK
BNT162b2
AstraZeneca
AZD1222
COVID-19
AstraZeneca's COVID-19 vaccine gets the green light in the UK
Biopharma Reporter
Wed, 12/30/20 - 10:59 am
UK
COVID-19
vaccines
AstraZeneca
Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China
Fierce Pharma
Wed, 12/30/20 - 10:53 am
Merck
Bristol-Myers Squibb
AstraZeneca
Roche
Keytruda
Opdivo
Imfinzi
Tecentriq
China
PD-1 inhibitors
UK expected to approve Oxford-AstraZeneca Covid vaccine this week
CNBC
Tue, 12/29/20 - 11:03 am
UK
vaccines
COVID-19
AstraZeneca
Merck and AstraZeneca's Cancer Drug Wins 3 New Approvals in Japan
Motley Fool
Tue, 12/29/20 - 10:57 am
Merck
AstraZeneca
Japan
ovarian cancer
prostate cancer
pancreatic cancer
Lynparza
Amgen-AstraZeneca Experimental Asthma Drug Surprisingly Flops in Phase III
BioSpace
Tue, 12/22/20 - 10:47 am
Amgen
AstraZeneca
asthma
clinical trials
tezepelumab
AstraZeneca, FibroGen's roxadustat hits snag at FDA, but analysts figure an approval's still on its way
Fierce Pharma
Mon, 12/21/20 - 11:46 pm
AstraZeneca
FibroGen
roxadustat
FDA
anemia
The top 5 pharma M&A deals of 2020
Pharmaforum
Mon, 12/21/20 - 11:07 am
M&A
AstraZeneca
Alexion
Gilead Sciences
Immunomedics
Forty Seven
JNJ
Momenta
Sanofi
Principia Biopharma
[video+transcript]Is AstraZeneca Paying Too Much for Alexion?
Motley Fool
Mon, 12/21/20 - 11:00 am
M&A
AstraZeneca
Alexion
Best-selling Tagrisso further outpaces an upcoming J&J rival, winning approval in new NSCLC indication
Endpoints
Mon, 12/21/20 - 10:59 am
AstraZeneca
Tagrisso
non-small cell lung cancer
JNJ
amivantamab

Pages